Literature DB >> 10602546

Dermatophytosis caused by Trichophyton raubitschekii. Report of the first case in São Paulo, Brazil.

C S Lacaz1, C Zaitz, L R Ruiz, V M de Souza, A R Santos, L H Muramatu, N T de Melo, E M Heins-Vaccari, G L Hernández-Arriagada, R S de Freitas-Leite.   

Abstract

The authors report the first case of dermatophytosis caused by Trichophyton raubitschekii in a patient from the State of São Paulo with Tinea corporis lesions localized on the buttocks. Culture on Sabouraud-agar with cycloheximide permitted the isolation and identification of the fungus, and the diagnosis was confirmed by Dr. Lynne Sigler, University of Alberta, Canada. Systemic treatment with fluconazole, 150 mg/week for 4 weeks, in combination with topical treatment with isoconazole initially yielded favorable results, with recurrence of the lesions after the medication was discontinued. This is the fifth case of this dermatophytosis published in the Brazilian medical literature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602546     DOI: 10.1590/s0036-46651999000500008

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  4 in total

1.  [The raubitschekii variant of Trichophyton rubrum has reached Germany].

Authors:  J Brasch; Y Gräser
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

2.  Trichophyton Rubrum with the 'raubitschekii' morphotype: the first report from Turkey.

Authors:  Macit Ilkit; Mehmet Ali Saraclı; Tuba Yuksel
Journal:  Mycopathologia       Date:  2010-08-22       Impact factor: 2.574

Review 3.  Generalized superficial mycosis caused by Trichophyton raubitschekii in China: case report and review of the literature.

Authors:  Hao Zhang; Xincai Xiong; Ting Liu; Yuping Ran
Journal:  Mycopathologia       Date:  2014-12-14       Impact factor: 2.574

4.  Urease-positive Trichophyton rubrum strains (previously described as T. raubitschekii): first isolations in Argentina.

Authors:  A van Gelderen de Komaid; I Borges de Kestelman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.